L-019
Lamotrigine solution
1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
About This Item
Produits recommandés
Qualité
certified reference material
Niveau de qualité
Forme
liquid
Caractéristiques
Snap-N-Spike®/Snap-N-Shoot®
Conditionnement
ampule of 1 mL
Fabricant/nom de marque
Cerilliant®
Concentration
1.0 mg/mL in methanol
Technique(s)
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
Application(s)
clinical testing
Format
single component solution
Température de stockage
−20°C
Chaîne SMILES
Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI
1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
Clé InChI
PYZRQGJRPPTADH-UHFFFAOYSA-N
Informations sur le gène
human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)
Description générale
Application
- Metabolic Impact in Bipolar Disorder: Lamotrigine is studied for its metabolic effects when used alongside antipsychotics in bipolar disorder management. The research, conducted through a network meta-analysis, provides insights into the mood stabilization and metabolic considerations during treatment (Kong et al., 2024).
- Forensic Application: Lamotrigine′s quantification in human plasma is critical in forensic science for ensuring accurate therapeutic monitoring and legal investigations. This application leverages HPLC-PDA techniques to analyze forensic samples, demonstrating the drug′s significance beyond clinical settings (Sánchez-Sellero et al., 2024).
- Advanced Drug Monitoring: A study has developed a method using LC-MS/MS for the simultaneous monitoring of lamotrigine among other antiepileptic drugs through dried blood and plasma spot sampling. This technique enhances the pharmacokinetic analysis and is pivotal for patient management in epilepsy treatment (Cao et al., 2024).
- Innovative Extraction Techniques: Research has introduced a molecularly imprinted polymer membrane for the selective extraction of lamotrigine, showcasing its utility in separating and quantifying this drug alongside other pharmaceuticals. This innovative approach benefits various biochemical assays and enhances drug analysis capabilities (Zhao et al., 2024).
- Enhanced Analytical Methodology: Lamotrigine′s determination in urine samples through a titania-based fabric phase sorptive extraction reflects its critical role in therapeutic drug monitoring. This method, paired with high-performance liquid chromatography, offers precise measurements essential for neurological disorder management (Ulusoy et al., 2024).
Informations légales
Produit(s) apparenté(s)
Mention d'avertissement
Danger
Mentions de danger
Conseils de prudence
Classification des risques
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
Organes cibles
Eyes,Central nervous system
Code de la classe de stockage
3 - Flammable liquids
Classe de danger pour l'eau (WGK)
WGK 2
Point d'éclair (°F)
49.5 °F - closed cup
Point d'éclair (°C)
9.7 °C - closed cup
Certificats d'analyse (COA)
Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Les clients ont également consulté
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique